Agios Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGAgios Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 59), indicating performance broadly in line with the market. Earnings contraction of 9% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $29.64 | +18.42% | ABOVE |
| 50 SMA | $29.07 | +20.73% | ABOVE |
| 100 SMA | $29.14 | +20.47% | ABOVE |
| 150 SMA | $28.94 | +21.27% | ABOVE |
| 200 SMA | $31.71 | +10.70% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AGIO in an uptrend right now?
AGIO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is AGIO overbought or oversold?
AGIO's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is AGIO outperforming the market?
AGIO has a Relative Strength (RS) Rating of 59 out of 99. AGIO is performing about average compared to the market.
Where is AGIO in its 52-week range?
AGIO is trading at $35.10, which is 76% of its 52-week high ($46.00) and 54% above its 52-week low ($22.24).
How volatile is AGIO?
AGIO has a Beta of 0.96 and 52-week volatility of 75%. It's less volatile than the S&P 500 - generally more stable.